Concurrent chemoradiotherapy for squamous cell carcinoma of the anus using a shrinking field radiotherapy technique without a boost

British Journal of Cancer

Volumn 88, Issue 9, 2003, Pages 1352-1357

  Melcher, A A ^a   Sebag Montefiore, D ^a  

^a Northern and Yorkshire Clinical Trials and Research Unit   (United Kingdom)

Author keywords

Anal cancer; Chemoradiation; Chemotherapy; Radiotherapy

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ANUS CARCINOMA; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLOSTOMY; DIARRHEA; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; NEUTROPENIA; PRIORITY JOURNAL; RADIATION DOSE; SALVAGE THERAPY; SEPSIS; SKIN EXFOLIATION; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM STAGING; NEOPLASMS, SQUAMOUS CELL; RADIOTHERAPY; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037809206     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600913     Document Type: Article

References (19)

1. Anonymous (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Coordinating Committee on Cancer Research. Lancet 348: 1049-1054
2. Allal AS, Sprangers MA, Laurencet F, Reymond MA, Kurtz JM (1999) Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy. Br J Cancer 80: 1588-1594
3. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15: 2040-2049
4. Chantler C, Garnett ES, Parsons V, Veall N (1969) Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA. Clin Sci 37: 169-180
5. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41
6. Cummings BJ, Keane TJ, O'Sullivan B, Wong CS, Carton CN (1991) Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 21: 1115-1125
7. Dzik-Jurasz AS, Brooker S, Husband JE, Tait D (2001) What is the prevalence of symptomatic or asymptomatic femoral head osteonecrosis in patients previously treated with chemoradiation? A magnetic resonance study of anal cancer patients. Clin Oncol 13: 130-134
8. Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L, Murray K (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14: 2527-2539
9. Hu K, Minsky BD, Cohen AM, Kelsen DP, Guillem JG, Paty PP, Quan SH (1999) 30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy. J Surg Oncol 70: 71-77
10. Jenkins PJ, Montefiore DJ, Arnott SJ (1995) Hip complications following chemoradiotherapy. Clin Oncol 7: 123-126
11. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Star Assoc 53: 457-481
12. Leichman L, Nigro N, Vaitkevicius VK, Considine B, Buroker T, Bradley G, Seydel HG, Olchowski S, Cummings G, Leichman C, et al (1985) Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy. Am J Med 78: 211-215
13. Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Kelsen DP (2002) INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy. J Clin Oncol 20: 1167-1174
14. Myerson RJ, Kong F, Birnbaum EH, Fleshman JW, Kodner IJ, Picus J, Ratkin GA, Read TE, Walz BJ (2001) Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. Radiother Oncol 61: 15-22
15. Myerson RJ, Shapiro SJ, Lacey D, Lopez M, Birnbaum E, Fleshman J, Fry R, Kodner I (1995) Carcinoma of the anal canal. Am J Clin Oncol 18: 32-39
16. Nigro ND, Seydel HG, Considine B, Vaitkevicius VK, Leichman L, Kinzie JJ (1983) Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 51: 1826-1829
17. Nigro KrD, Vaitkevicius VK, Considine Jr B (1974) Combined therapy for cancer of the anal canal: a preliminary report. 1974. Dis Colon Rectum 17: 354-356
18. Northover JM (1991) Epidermoid cancer of the anus - the surgeon retreats. J R Soc Med 84: 389-390
19. Weber DC, Kurtz JM, Allal AS (2001) The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys 50: 675-680